This page shows the latest neurodegenerative diseases news and features for those working in and with pharma, biotech and healthcare.
The collaboration combines Washington University’s expertise in research focused on neurodegenerative diseases with the Japan-based pharma’s experience in drug discovery and development. ... Commenting on the latest collaboration between the two
In line with the FDA Rare Neurodegenerative Disease Grant Program, which was recently established specifically for ALS and other rare neurodegenerative diseases, three of the natural history studies awarded by the ... Additionally, the two FDA funded
There are currently very few effective treatments for dementia or other neurodegenerative diseases such as Parkinson’s disease. ... This means investing in diagnostic infrastructure, piloting the use of new detection technologies like that being
other neurodegenerative disorders. ... Kv1.3 plays an important role in creating and maintaining neuroinflammation in Parkinson's and other neurodegenerative diseases.
Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio and lead author of the study.
The US Food and Drug Administration (FDA) and the National Institutes of Health (NIH) have launched a public-private partnership aimed at advancing the understanding of neurodegenerative diseases, the organisations announced. ... The goal of the
More from news
Approximately 5 fully matching, plus 78 partially matching documents found.
Biological medicines represent a major advance in the treatment of serious pathological conditions such as cancer, neurodegenerative and autoimmune diseases, in the form of biosimilars. ... For orphan designations (medicine for rare diseases),
Advances in technology are providing huge opportunities to intervene decades earlier, when these diseases first start to take hold. ... That’s where the Early Detection of Neurodegenerative diseases (EDoN) initiative comes in.
and a decade as senior director of neurodegenerative diseases research at Merck Serono where he served as its leader for in vitro pharmacology in neurology, including in multiple sclerosis, Parkinson’s ... and Alzheimer’s diseases.
big diseases in the field, such as Alzheimer’s, is too limited to make near-term success likely. ... Based on what we felt was the state of the art in terms of understanding the pathogenesis of major diseases, especially neurodegenerative diseases, and
Nevertheless, strategies for developing successful therapeutic interventions are shifting. We have developed a five-point roadmap to successful treatments for Alzheimer’s disease and neurodegenerative diseases. ... Hyper-stimulation of microglial cells
More from intelligence
Approximately 0 fully matching, plus 15 partially matching documents found.
to tackle unmet needs in neurological diseases.”. ... I'm excited to work with Biogen's innovative and talented team as we work to expand the company's portfolio of therapies for people living with serious neurodegenerative diseases.”.
Francois Nader joins the biotech. Prevail Therapeutics, a biotechnology company focused on the development of gene therapies for patients with neurodegenerative diseases, has strengthened its board of directors with the addition ... The Prevail team has
Novartis’ Michael Ryan joins the neurodegenerative diseases specialist. Lausanne, Switzerland-based Asceneuron has appointed Michael Ryan as its new chief medical officer. ... He joins the neurodegenerative diseases specialist from Novartis, where he
Prof De Strooper is currently a professor of molecular medicine at the University of Leuven and leads its laboratory for the research of neurodegenerative diseases.
neurodegenerative and rare diseases around the world.
More from appointments
Approximately 0 fully matching, plus 12 partially matching documents found.
Richie Bavasso, founder and CEO of nQMedical, discusses everything from digital therapeutics, diagnostics, and other data-driven solutions for neurodegenerative diseases to Richie’s favorite media outlets, his work at nQMedical,
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Genetic Digital specialises in developing digital marketing solutions for the healthcare, medical and pharmaceutical sectors. From developing a digital strategy,...